3D Printing Benefiting Cystic Fibrosis Drug Delivery

Written by Patrícia Silva, PhD |

Prototype

Cystic Fibrosis (CF), one of the most common genetic diseases among Caucasian children, is classified as an orphan disease, estimated to affect roughly 70,000 individuals worldwide, 30,000 of which live in the United States. While there are several subsidies that cater to research and development initiatives on treatments for rare diseases, creating and launching medical devices can be a challenge in today’s healthcare market. Thanks to open-source collaborations and additive manufacturing techniques, promising products indicated for a relatively small target market can bypass the usual process for commercialization.

A group of researchers from the University of SheffieldSheffield Hallam University and the Northern General Hospital in the United Kingdom recently included the CF community in the design of a unique pill dispenser for a digestive enzyme formulation called Creon (pancrelipase), which is distributed by AbbVie. Creon is available in capsule form, and is recommended to be taken with meals so it can mix with food before nutrient absorption in the small intestine takes place.

[adrotate group=”1″]

Plasticinsert

While these capsules currently come in their own hockey puck-like container, many are inconvenienced by its size and tendency to rattle when carried around in public. Some take to transferring the capsules in smaller containers, but this does not help in dose tracking, as some patients are prescribed more than 12 capsules a day.

The lead designer on this project is Matt Dexter, who teamed up with the UK researchers and presented their creation at the 37th European Cystic Fibrosis Conference in Gothenburg, Sweden last June.

The most helpful method the team used to bring their ideas to life is 3D printing by MakerBot, which helped them build Pez-like prototypes for online evaluation by the CF community.

In the near future, the creators plan to integrate an electronic dose counter to help in monitoring treatment compliance. Those interested to participate in this open-source project can download the files from Thingiverse.

 

Brian Eddy avatar

Brian Eddy

"help in monitoring treatment compliance" - didn't realize CF patients were prisoners subject to discipline by medical providers.

Reply
Mr Carmichael avatar

Mr Carmichael

10th September 2017

I serioursly take offence at the comment that was posted by Mr Eddy. I was born with a unique variation of Cystic Fibrosis which I have had since birth and, speaking from 34 years of experience, anything that helps when it comes to having to take numerous amounts of pills on a daily basis as a matter of survival rather than choice is seriously genuinely appreciated.

Reply
Miss Parnell avatar

Miss Parnell

I agree with Mr Carmichael. My father has lived with Bronchiectasis for 60yrs. The mucus build up on his organs has now caused a very rare form of Pancreatic Cancer. He know takes 45-50 creon tablets a day, sometimes more depending on what he’s eaten. It has taken over his life, so for a CF sufferer, dealing with creon everyday must be exhausting. I have come across this page after my partner commented that a Pez type dispenser would be a handy way of discretely taking the capsules throughout the day. Carrying around tablet boxes that are bulky is very inconvenient. I was surprised to see that nobody had designed something like that sooner. It just shows how people with certain medical issues suffer in silence or get forgotten!!
I hope Mr Carmichael, that you haven’t found yourself struggling to get Creon due the national shortage. Again, another stressful issue regarding a tablet needed for survival that is swept under the carpet!
My father and our family appreciate any help regarding the tablets

Reply

Leave a comment

Fill in the required fields to post. Your email address will not be published.

Comments are moderated. Once approved, your comment and username will be publicly visible. Please avoid sharing personal health information or other sensitive details.